Publications:

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.

Ebiomedicine

Sun, Hao H; Liu, Si-Yang SY; Zhou, Jia-Ying JY; Xu, Jin-Tian JT; Zhang, Huang-Kai HK; Yan, Hong-Hong HH; Huan, Jiao-Jiao JJ; Dai, Ping-Ping PP; Xu, Chong-Rui CR; Su, Jian J; Guan, Yan-Fang YF; Yi, Xin X; Yu, Rong-Shan RS; Zhong, Wen-Zhao WZ; Wu, Yi-Long YL

Publication Date: 2020-10

Variant appearance in text: MSH6: 649G>T; Asp217Tyr

PubMed Link: 32927274

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease.

British Journal Of Cancer

Pinto, C C; Veiga, I I; Pinheiro, M M; Mesquita, B B; Jeronimo, C C; Sousa, O O; Fragoso, M M; Santos, L L; Moreira-Dias, L L; Baptista, M M; Lopes, C C; Castedo, S S; Teixeira, M R MR

Publication Date: 2006-09-18

Variant appearance in text: MSH6: D217Y

PubMed Link: 16940983

Variant Present in the following documents:

• Main text
• 95-6603318a.pdf

View BVdb publication page